http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-4770983-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_edb937a3f24d311503cf2a4911093eb7 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42 |
| filingDate | 1996-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b8fdd048d91ac6ebb37509e7dac5e1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1af16bc81248b902bfdf02cf1e77c4aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f95c9003c2278b093b311b9e810bc6e7 |
| publicationDate | 1999-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CO-4770983-A1 |
| titleOfInvention | METHOD AND COMPOSITION FOR THE TREATMENT OF OSTEOPOROSIS |
| abstract | The combination of the following two active agents for the treatment of osteoporosis in humans is presented: (a) A pharmacologically acceptable alkalinizing potassium salt that produces hydroxyl ions and is consequently capable of reducing the acidity of tissue fluids or of urine, and that it selects from the group consisting of potassium bicarbonate and potassium salts of carboxylic acids that are metabolized to bicarbonate and thus produce alkalinity in vivo of one of the following formulas: (a´) and (b) A bisphosphate that be effective as an anti-absorbent agent for bones in the treatment of osteosporosis of the formula: administering the active ingredients in effective amounts to treat osteoporosis without adversely affecting the bones and acid-basic homosteosis. |
| priorityDate | 1996-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.